IP Verse

Liquid Pharmaceutical Formulation - EP3773498

The patent EP3773498 was granted to Project Pharmaceutics on Jun 22, 2022. The application was originally filed on Mar 29, 2019 under application number EP19719428A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3773498

PROJECT PHARMACEUTICS
Application Number
EP19719428A
Filing Date
Mar 29, 2019
Status
Granted And Under Opposition
May 20, 2022
Grant Date
Jun 22, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ONCOPEPTIDESMar 22, 2023ABEL & IMRAYADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO2011094565
DESCRIPTIONWO2013112762
INTERNATIONAL-SEARCH-REPORTUS2014005148
INTERNATIONAL-SEARCH-REPORTWO2010036702
INTERNATIONAL-SEARCH-REPORTWO2011094565
INTERNATIONAL-SEARCH-REPORTWO2013112762
INTERNATIONAL-SEARCH-REPORTWO2017002030
OPPOSITIONCA1162479
OPPOSITIONCN101856325
OPPOSITIONDD159289
OPPOSITIONJPH11292767
OPPOSITIONJPS63239237
OPPOSITIONLU100750
OPPOSITIONUS2014005148
OPPOSITIONWO2010036702
OPPOSITIONWO2011094565
OPPOSITIONWO2015138199
OPPOSITIONWO2017002030
OPPOSITIONWO2019185859
OPPOSITIONWO9533487

Non-Patent Literature (NPL) Citations (6) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "Cisplatin", (20171213), pages 1 - 7, Wikipedia , URL: https://web.archive.org/web/20171213225742/https://en.wikipedia.org/wiki/Cisplatin, (20230922), XP093084912-
OPPOSITION- Anonymous, "Highlights of Prescribing Information(Bendamustine hydrochloride injection)", BELRAPZO, (20180801), no. 4314875, pages 1 - 23, XP093085295-
OPPOSITION- Pearson R G, "Hard and Soft Acids and bases HSAB , Part 1", Journal of chemical education, US , (19680901), vol. 45, no. 9, ISSN 0021-9584, pages 581 - 587, XP000981434-
OPPOSITION- Pellett M A, "Calcium Chloride", Pellett M A, Paul J. Sheskey (ed.), Handbook of Pharmaceutical Excipients. 8th ed., London , Pharmaceutical Press , (20170101), pages 141 - 143, ISBN 978-0-85711-271-2, XP093085301-
OPPOSITION- Ralph G. Pearson, "Acids and bases", Science, (19660114), vol. 151, no. 3707, ISSN 0036-8075, pages 172 - 177, XP093084926-
OPPOSITION- Johnson Kevin M., Parsons Zachary D., Barnes Charles L., Gates Kent S., "Toward Hypoxia-Selective DNA-Alkylating Agents Built by Grafting Nitrogen Mustards onto the Bioreductively Activated, Hypoxia-Selective DNA-Oxidizing Agent 3-Amino-1,2,4-benzotriazine 1,4-Dioxide (Tirapazamine)", The Journal of Organic Chemistry, (20140815), vol. 79, no. 16, doi:10.1021/jo501252p, ISSN 0022-3263, pages 7520 - 7531, XP093084902

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents